Advantage Investment Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $9K | Hold |
200
| – | – | 0.01% | 670 |
|
|
2019
Q2 | $11K | Hold |
200
| – | – | 0.01% | 645 |
|
|
2019
Q1 | $11K | Hold |
200
| – | – | 0.01% | 630 |
|
|
2018
Q4 | $9K | Hold |
200
| – | – | 0.01% | 681 |
|
|
2018
Q3 | $12K | Hold |
200
| – | – | 0.01% | 674 |
|
|
2018
Q2 | $11K | Hold |
200
| – | – | 0.01% | 635 |
|
|
2018
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 680 |
|
|
2017
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 713 |
|
|
2017
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 691 |
|
|
2017
Q2 | $9K | Hold |
200
| – | – | ﹤0.01% | 726 |
|
|
2017
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 729 |
|
|
2016
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 677 |
|
|
2016
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 660 |
|
|
2016
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 653 |
|
|
2016
Q1 | $8K | Buy |
200
+100
| +100% | +$4K | ﹤0.01% | 601 |
|
|
2015
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 688 |
|
|
2015
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 661 |
|
|
2015
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 675 |
|
|
2015
Q1 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 668 |
|